September 25, 2026 at 09:40 PM UTC
Calidi Biotherapeutics, Inc. reports listing or compliance development
Calidi Biotherapeutics, Inc. filed an 8-K covering a listing or compliance notice and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: September 25, 2026 at 09:15 PM UTC
Open official source